Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries-Reference-Cited by-同舟云学术

Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries

Published:2019-11-25 Issue:18 Volume:20 Page:2237-2255
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Godman Brian¹²³⁴^ORCID,Grobler Christoffel⁵⁶⁷^ORCID,Van-De-Lisle Marianne⁸,Wale Janney⁹,Barbosa Wallace Breno¹⁰^ORCID,Massele Amos¹¹,Opondo Philip¹²^ORCID,Petrova Guenka¹³^ORCID,Tachkov Konstantin¹³^ORCID,Sefah Israel¹⁴^ORCID,Abdulsalim Suhaj¹⁵,Alrasheedy Alian A.¹⁵^ORCID,Unnikrishnan Mazhuvancherry Kesavan¹⁶,Garuoliene Kristina¹⁷,Bamitale Kayode¹⁸,Kibuule Dan¹⁸^ORCID,Kalemeera Francis¹⁸,Fadare Joseph¹⁹,Khan Tanveer Ahmed²⁰,Hussain Shahzad²⁰,Bochenek Tomasz²¹,Kalungia Aubrey Chichonyi²²^ORCID,Mwanza James²³,Martin Antony P⁴²⁴,Hill Ruaraidh²⁵,Barbui Corrado²⁶^ORCID

Affiliation:

1. Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedicial Sciences, University of Strathclyde, Glasgow, UK

2. Division of Clinical Pharmacology, Karolinska, Karolinska Institutet, Stockholm, Sweden

3. Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa

4. Health Economics Centre, University of Liverpool Management School, Liverpool, UK

5. Elizabeth Donkin Hospital, Port Elizabeth, South Africa

6. Walter Sisulu University, East London, South Africa

7. Nelson Mandela University, Port Elizabeth, South Africa

8. Lead Clinical Pharmacist, Royal Edinburgh Hospital, Edinburgh, UK

9. Independent consumer advocate, Brunswick, Australia

10. Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil

11. Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana

12. Department of Psychiatry, Faculty of Medicine, University of Botswana, Gaborone, Botswana

13. Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria

14. Department of Pharmacy, Keta Municipal Hospital, Ghana Health Service, Keta, Ghana

15. Unaizah College of Pharmacy, Qassim University, Buraidah Saudi Arabia

16. Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, India

17. Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, Lithuania and Ministry of Health, Vilnius, Lithuania

18. School of Pharmacy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia

19. Department of Pharmacology and Therapeutics, College of Medicine, Ekiti State University, Ado-Ekiti, Nigeria

20. National Institute of Health, Islamabad, Pakistan

21. Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland

22. Department of Pharmacy, University of Zambia, Lusaka, Zambia

23. Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Zambia, Lusaka, Zambia

24. HCD Economics, The Innovation Centre, Daresbury, UK

25. Liverpool Reviews and Implementation Group, Whelan Building, Liverpool University, Liverpool, UK

26. WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1684473

Reference206 articles.

1. Estimating the true global burden of mental illness

2. Mental health in low- and middle-income countries

3. WHO. World Health Organization, Calouste Gulbenkian Foundation. Improving access to and appropriate use of medicines for mental disorders. Geneva. Available from: http://apps.who.int/iris/bitstream/10665/254794/1/9789241511421-eng.pdf?ua=1

4. The mental health workforce gap in low- and middle-income countries: a needs-based approach

5. Undertreatment of people with major depressive disorder in 21 countries

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of Recent Antibiotic Prescribing Practices in Ambulatory Care in Tanzania: Findings and Implications;Medicina;2023-12-18

2. A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance;Antibiotics;2023-10-14

3. Digital measures in epilepsy in low-resourced environments;Expert Review of Pharmacoeconomics & Outcomes Research;2023-10-11

4. Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance;Expert Review of Anti-infective Therapy;2023-10-03

5. Mental Health Challenges during COVID-19 Pandemic: Experiences of Primary Healthcare Nurses in Durban, South Africa;International Journal of Environmental Research and Public Health;2023-08-30